Basal Cell Carcinoma: A Comprehensive Review

Emi Dika,Federica Scarfì,Manuela Ferracin,Elisabetta Broseghini,Emanuela Marcelli,Barbara Bortolani,Elena Campione,Mattia Riefolo,Costantino Ricci,Martina Lambertini
DOI: https://doi.org/10.3390/ijms21155572
IF: 5.6
2020-08-04
International Journal of Molecular Sciences
Abstract:Basal cell carcinoma (BCC) is the most common type of carcinoma worldwide. BCC development is the result of a complex interaction between environmental, phenotypic and genetic factors. However, despite the progress in the field, BCC biology and mechanisms of resistance against systemic treatments have been poorly investigated. The aim of the present review is to provide a revision of BCC histological and molecular features, including microRNA (miRNA) dysregulation, with a specific focus on the molecular basis of BCC systemic therapies. Papers from the last ten years regarding BCC genetic and phenotypic alterations, as well as the mechanism of resistance against hedgehog pathway inhibitors vismodegib and sonidegib were included. The involvement of miRNAs in BCC resistance to systemic therapies is emerging as a new field of knowledge.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?